Febuton
Brand Name: Febuton
Generic Name: Febuxostat
Active
Registration Number
DR-XY47235
Dosage Form
Film-Coated Tablet
Issuance Date
June 1, 2021
Expiry Date
June 1, 2026
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength80 mg
PackagingAlu/PVDC Blister Pack x 14's (Box of 28's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antihyerpuricemia
A
Application
Initial
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
FebuxostatActive
Monograph: Febuxostat